Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Elan Corp. PLC ADS (NY: ELN)
13.78 USD  +0.29 (+2.15%)
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Elan Corp. PLC ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Royalty Pharma Announces Withdrawal Of Judicial Review And Lapse Of Offer
Today 6:43 EDT
from PR Newswire
Elan Advises Shareholders to Withdraw Any Acceptances of the Royalty Pharma Offer and Not to Tender Any Further Acceptances into This Lapsed Offer*
Today 2:00 EDT
from Business Wire News Releases
In The Know, Smart Investing In JPM, T, WFC and ELN
June 17, 2013
from Marketwired News Releases
Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today
June 17, 2013
from PR Newswire
Elan Announces Results of EGM
June 17, 2013
from Business Wire News Releases
Royalty Pharma Chairman Writes Open Letter to Elan Board
June 17, 2013
Expresses Disappointment at Elan's Unwillingness to Negotiate Improved Terms in a Recommended Transaction Structured as a Scheme of Arrangement Read More
from PR Newswire
Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty
June 14, 2013
Ordinary Shareholders Urged to Vote AGAINST All Four Proposals Today to Allow Royalty Pharma's Offer of $13 per Share Plus an up to $2.50 CVR to Move Forward Read More
from PR Newswire
Elan To Proceed with Formal Sale Process
June 14, 2013
from Business Wire News Releases
Strategy Behind Our Success, We Get in Early: GE, ELN, F and C
June 14, 2013
from Marketwired News Releases
Reveal Insider Trading for Safeway, Facebook, Cisco, Citigroup, Elan, and Myriad Genetics
June 14, 2013
from PR Newswire
Elan ADS Holders Decisively Vote Against Theravance And AOP Transactions
June 14, 2013
VOTE OF ORDINARY SHAREHOLDERS MAY DETERMINE WHETHER ROYALTY PHARMA'S OFFER OF $13 IN CASH PLUS AN UP TO $2.50 CVR WILL BE PERMITTED TO PROCEED Read More
from PR Newswire
Earning Forecast Highlight for Pfizer, Bank of America, Lululemon Athletica, Facebook, Elan, and QUALCOMM
June 13, 2013
from PR Newswire
Royalty Pharma Announces Offer May Lapse (Be Withdrawn)
June 13, 2013
from PR Newswire
The Straight Truth, Investing in CTB, C, NCT and ELN
June 13, 2013
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: MNKD, ELN, SAN and CHK
June 12, 2013
from Marketwired News Releases
Royalty Pharma Files Judicial Review Proceedings
June 11, 2013
from PR Newswire
In Royalty Pharma's View, Elan's EGM Circular is Misleading and Omits Key Information that Elan Shareholders Need to Make an Informed Decision
June 11, 2013
IF ELAN STOCKHOLDERS APPROVE ANY OF THE FOUR PROPOSED TRANSACTIONS, ROYALTY PHARMA WILL BE REQUIRED TO LAPSE ITS OFFER(I),(II) Read More
from PR Newswire
Elan Issues Open Letter Urging Shareholders to Vote Today IN FAVOR of All Four EGM Resolutions
June 11, 2013
from Business Wire News Releases
The Reason It Trades, What's Moving ELN, RF, C and T
June 11, 2013
from Marketwired News Releases
Royalty Pharma Acceptances Announcement
June 11, 2013
from PR Newswire
Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan
June 10, 2013
Urges Shareholders to Vote AGAINST ALL PROPOSALS at Upcoming Elan EGM Read More
from PR Newswire
Elan Withdraws Lawsuit – Royalty Pharma Made Significant Additional Disclosure
June 10, 2013
from Business Wire News Releases
Where Opportunity Is Found in GM, ELN, QCOM and EMC
June 10, 2013
from Marketwired News Releases
Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
June 10, 2013
ADS Shareholders Have Only Three Days to Vote Read More
from PR Newswire
Royalty Pharma Posts Further Revised Offer Document In Offer For Elan Corporation, Plc ("Elan")
June 10, 2013
from PR Newswire
Elan Board Of Directors Unanimously And Without Reservation Rejects Royalty Pharma's Revised Tender Offer
June 10, 2013
from Business Wire News Releases
Elan’s Response to Royalty Pharma Announcement
June 07, 2013
from Business Wire News Releases
Royalty Pharma Increases Offer to Acquire Elan to $13.00 Per Share in Cash Plus a Contingent Value Right of Up to $2.50 Per Share
June 07, 2013
CVR Allows Shareholders to Participate in Tysabri Royalty Upside for all Indications and Cash Flows, Pre- and Post-Patent Expiration Read More
from PR Newswire
Royalty Pharma Acceptances Announcement
June 07, 2013
from PR Newswire
Elan’s Response to Irish Takeover Panel Rulings
June 06, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here